Cigna's most recent trend suggests a bullish bias. One trading opportunity on Cigna is a Bull Put Spread using a strike $185.00 short put and a strike $180.00 long put offers a potential 15.21% return on risk over the next 20 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $185.00 by expiration. The full premium credit of $0.66 would be kept by the premium seller. The risk of $4.34 would be incurred if the stock dropped below the $180.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Cigna is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Cigna is bullish.
The RSI indicator is at 69.47 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Cigna
Cigna Corporation Announces Appearance at the 2018 Morgan Stanley Healthcare Conference
Mon, 27 Aug 2018 10:00:00 +0000
Global health service company Cigna announced today that David Cordani, President and Chief Executive Officer will present at the 2018 Morgan Stanley Healthcare Conference on September 13, 2018 in New York City, NY.
Cigna Corporation (NYSE:CI): The Yield That Matters The Most
Sun, 26 Aug 2018 14:20:37 +0000
If you are currently a shareholder in Cigna Corporation (NYSE:CI), or considering investing in the stock, you need to examine how the business generates cash, and how it is reinvested.Read More…
[$$] Shareholders Approve Cigna-Express Scripts Deal
Sat, 25 Aug 2018 00:19:24 +0000
Cigna Corp. and Express Scripts Holding Co. shareholders overwhelmingly supported Cigna’s $54 billion purchase of the pharmacy-benefit manager, a deal that activist investor Carl Icahn initially sought to block. The deal received the backing of about 90% of Cigna shareholders, the health insurer said Friday, citing a preliminary vote tally. Of the Express Scripts shareholders who voted Friday, 99% approved the deal.
Cigna, Express Scripts shareholders vote to approve merger
Fri, 24 Aug 2018 17:56:00 +0000
Activist investor Carl Icahn opposed the deal but dropped his fight after influential proxy advisory firms Glass Lewis and Institutional Shareholder Services and hedge fund Glenview Capital Management …
Cigna, Express Scripts shareholders vote for planned combo
Fri, 24 Aug 2018 15:56:34 +0000
Cigna shareholders are backing the insurer's planned takeover of pharmacy benefit manager Express Scripts, a deal that activist investor Carl Icahn had urged them to reject earlier this month. Cigna says about 90 percent of votes cast on Friday were in favor of the roughly $52-billion deal, which also received broad approval from Express Scripts shareholders. Icahn had warned shareholders in an open letter that Cigna Corp. was paying too much for St. Louis-based Express Scripts Holding Co. But other shareholders and the proxy advisory firm Institutional Shareholder Services backed the acquisition plan, which was announced earlier this year.
Related Posts
Also on Market Tamer…
Follow Us on Facebook